S.2210 - Medical Innovation Prize Act of 2007

A bill to provide incentives for investment in research and development for new medicines, to enhance access to new medicines, and for other purposes. view all titles (2)

Close

All Bill Titles

  • Official: A bill to provide incentives for investment in research and development for new medicines, to enhance access to new medicines, and for other purposes. as introduced.
  • Short: Medical Innovation Prize Act of 2007 as introduced.

This Bill currently has no wiki content. If you would like to create a wiki entry for this bill, please Login, and then select the wiki tab to create it.

11/18/08
HIF on the Sanders prize fund bill - Knowledge Ecology Notes

In their recent book on the Health Impact Fund,* Aidan Hollis and Thomas Pogge discuss a number of issues. This is what they say about S.2210 (110th Congress), Senator Sanders’ proposal for the Medical Innovation Prize Fund. ...

Source: Knowledge Ecology Notes
11/17/08
The Health Impact Fund and product monopolies

... and which were incorporated in the two Sanders bills (HR 417, 109th Congress, S.2210, 110th Congress) and a variety of other proposals, including those most recently advanced by Barbados and Bolivia in the WHO discussions. ...

Source: Knowledge Ecology Notes
06/24/08
John McCain’s Prize System: $300 Million for Battery Power

Now Pending S.2210 is the "Medical Innovation Prize Act of 2007." The act would attempt to "de-couple" the reward for pharmaceutical product research from the market price of the product. Unlike more traditional prizes, this one would .

Source: Patent Law Blog (Patently-O)
04/20/08
James Love: University patent managers versus developing countries

A number of experts agree with this approach, which is also set forth in S.2210, the Medical Innovation Prize Fund. The debate in the WHO is actually much more limited. For example, Barbados and Bolivia recently proposed five different ...

Source: The Full Feed from HuffingtonPost.com
04/19/08
James Love: University Patent Managers Versus Developing Countries

A number of experts agree with this approach, which is also set forth in S.2210, the Medical Innovation Prize Fund. The debate in the WHO is actually much more limited. For example, Barbados and Bolivia recently proposed five different ...

Source: Business on HuffingtonPost.com
04/19/08
Thomson corp

A number of experts agree with this approach, which is also set forth in S.2210, the Medical Innovation Prize Fund. The debate in the WHO is actually much more limited. For example, Barbados and Bolivia recently proposed five different ...

Source: Swords in the Angel
04/01/08
A Federally Funded Institute To Compare Drugs? // Pharmalot

If this tentative legislation was put together with a Medical Innovation Prize Act http://thomas.loc.gov/cgi-bin/query/z?c110:S.2210: instead of the current pricing & reimbursement arrangements then we’d have better & cheaper medicines ...

Source: Pharmalot
02/06/08
Workshop Friday on alternative of prizes, not patents, to promote ...

This will include, but not be limited to, a discussion of the proposed Medical Prize Fund Act of 2007 (S.2210, 110th Congress) introduced by US Senator Bernie Sanders. As I pointed out recently:. "It is natural for consumers to distrust ...

Source: US PIRG Consumer Blog
02/05/08
Про медичні винаходи

Tim Hubbard, Wellcome Trust Sanger Institute. http://www.keionline.org/misc-docs/Prizes/bigidea_prizes4rnd_kchikent_vol82no3.pdf. David Reynold's presentation on the US Medical Innovation Prize Fund (S.2210, 110th Congress) ...

Source: Спільнота a2k
12/02/07
Geschäftsordnung Deutscher Bundestag ( GOBT ) Stand 2006

Geschäftsordnung des Deutschen Bundestages Geschäftsordnung des Deutschen Bundestages in der Fassung der Bekanntmachung vom 2. Juli 1980 (BGBl. I S. 1237), zuletzt geändert laut Bekanntmachung vom 26. September 2006 (BGBl. I S. 2210)

Source: Fun und Spass - Tibia und Politologie
10/28/07
Sen. Sanders Introduces Bill to End Market Exclusivity and Create ...

Earlier this month, Senator Bernie Sanders (I-VT) announced the introduction of the “Medical Innovation Prize Act of 2007” (S. 2210). If enacted, the bill would replace the current patent and non-patent market exclusivity system for ...

Source: FDA Law Blog
10/18/07
S. 2210, A bill to provide incentives for investment in research ...

S. 2210 would provide incentives for investment in research and development for new medicines, and it would enhance access to new medicines....

Source: WashingtonWatch.com - Welcome to WashingtonWatc...
10/18/07
Bill Action: Introduced: S. 2210: A bill to provide incentives for ...

Bernard Sanders [I-VT] introduced S. 2210: A bill to provide incentives for investment in research and development for new medicines, to enhance access to new medicines, and for other purposes. [This event matched these trackers: Active ...

Source: Active Legislation -- Tracked by GovTrack.us
Information made available by Technorati

Bill's Views

  • Today: 2
  • Past Seven Days: 18
  • All-Time: 944

80%

Users Support Bill

4 in favor / 1 opposed
Write Your Senators
Track with MyOC

OpenCongress is a free and open-source joint project of two non-profit organizations, the Participatory Politics Foundation and the Sunlight Foundation.